Areas of interest

COVID-19 Endometriosis Inflammation and cancer Inflammatory bowel disease (IBD) Influenza Lung cancer Microbiome in health and disease Ovarian cancer

Research group

Regulation of Interferon and Innate Signalling

Biography

A/Prof Edward Giles joined CiiiD in February 2016 as a clinician-scientist and performs research on the mucosal immunology of inflammatory bowel diseases (IBD), particularly the role of type I interferons and their influence on the adaptive immune system and microbiome of the intestine.

At the same time, A/Prof Giles has an appointment as a Consultant Paediatric Gastroenterologist at the Monash Children’s Hospital of the Monash Health network, where he is lead for paediatric IBD and has established a specific clinic for young adult patients with inflammatory bowel diseases in close collaboration with Dr Greg Moore, head of adult IBD at Monash Health. This is a unique clinical service in Victoria and is modelled on a clinic Dr Giles ran jointly in the UK.

He is a Fellow of the Royal Australasian College of Physicians and was awarded his PhD on Type I Interferon Signaling in human intestinal T Cells from the University of London in 2015. In 2017, he was appointed to the Gastroenterological Society of Australia (GESA) research committee.